PGC-1α Thr394Thr and Gly482Ser variants are significantly associated with T2DM in two North Indian populations:: a replicate case-control study

被引:51
作者
Bhat, Audesh
Koul, Anil
Rai, Ekta
Sharma, Swarkar
Dhar, M. K.
Bamezai, R. N. K. [1 ]
机构
[1] Jawaharlal Nehru Univ, Sch Life Sci, Natl Ctr Appl Human Genet, New Delhi 110067, India
[2] Univ Jammu, Dept Biotechnol, Jammu 180004, India
关键词
D O I
10.1007/s00439-007-0352-0
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
The recent observations that Peroxisome proliferator activated receptor gamma coactivator 1 alpha (PGC1A) is responsible for the induction of reactive oxygen species (ROS) detoxifying agents and that ROS triggers insulin resistance, support the role that this gene could play in the onset of Type 2 diabetes mellitus (T2DM). Two PGC1A variants Thr394Thr (rs2970847) and Gly482Ser (rs8192673) were genotyped in 822 subjects (351 T2DM cases and 471 controls) from two North Indian populations, represented as Group 1 (Kashmir population) and Group 2 (Punjab and Jammu population). Both Groups 1 and 2 showed a significant association of Thr394Thr variant with T2DM after applying Bonferroni corrections (P = 0.001 and 0.012, respectively). Logistic regression analysis for Thr394Thr susceptible genotypes together (rs2970847 G/A and A/A) conferred a 1.89-(95%CI 1.25-2.85) fold higher risk for T2DM in Group 1 and 1.81-(95%CI 1.19-2.78) fold risk in Group 2. The susceptible, Ser482 (rs8192673 G/A and A/A) genotypes, gave a 2.04 (95%CI 1.47-3.03) fold higher risk for T2DM in Group 1. Mitochondrial genotype backgrounds observed in association with T2DM (Bhat et al. 2007), when studied in combination with PGC1A variants, showed an increased prevalence in controls with mt10398G and 16189T along with G/G genotype background at the two polymorphic loci of PGC1A. These observations suggest that the two genotype backgrounds together could provide protection against T2DM.
引用
收藏
页码:609 / 614
页数:6
相关论文
共 27 条
  • [1] Mutation analysis of three genes encoding novel LKB1-interacting proteins, BRG1, STRADα, and MO25α, in Peutz-Jeghers syndrome
    Alhopuro, P
    Katajisto, P
    Lehtonen, R
    Ylisaukko-oja, SK
    Näätsaari, L
    Karhu, A
    Westerman, AM
    Wilson, JHP
    de Rooij, FWM
    Vogel, T
    Moeslein, G
    Tomlinson, IP
    Aaltonen, LA
    Mäkelä, TP
    Launonen, V
    [J]. BRITISH JOURNAL OF CANCER, 2005, 92 (06) : 1126 - 1129
  • [2] A calpain-10 gene polymorphism is associated with reduced muscle mRNA levels and insulin resistance
    Baier, LJ
    Permana, PA
    Yang, XL
    Pratley, RE
    Hanson, RL
    Shen, GQ
    Mott, D
    Knowler, WC
    Cox, NJ
    Horikawa, Y
    Oda, N
    Bell, GI
    Bogardus, C
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2000, 106 (07) : R69 - R73
  • [3] Meta-analysis of the Gly482Ser variant in PPARGC1A in type 2 diabetes and related phenotypes
    Barroso, I
    Luan, J
    Sandhu, MS
    Franks, PW
    Crowley, V
    Schafer, AJ
    O'Rahilly, S
    Wareham, NJ
    [J]. DIABETOLOGIA, 2006, 49 (03) : 501 - 505
  • [4] The possible role of 10398A and 16189C mtDNA variants in providing susceptibility toT2DM in two North Indian populations: a replicative study
    Bhat, Audesh
    Koul, Anil
    Sharma, Swarkar
    Rai, Ekta
    Bukhari, S. I. A.
    Dhar, M. K.
    Bamezai, R. N. K.
    [J]. HUMAN GENETICS, 2007, 120 (06) : 821 - 826
  • [5] Impaired coactivator activity of the Gly482 variant of peroxisome proliferator-activated receptor γ coactivator-1α (PGC-1α) on mitochondrial transcription factor A (Tfam) promoter
    Choi, Yon-Sik
    Hong, Jung-Man
    Lim, Sunny
    Ko, Kyung Soo
    Pak, Youngmi Kim
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2006, 344 (03) : 708 - 712
  • [6] Transcriptional repression of PGC-α by mutant huntingtin leads to mitochondrial dysfunction and neurodegeneration
    Cui, Libin
    Jeong, Hyunkyung
    Borovecki, Fran
    Parkhurst, Christopher N.
    Tanese, Naoko
    Krainc, Dimitri
    [J]. CELL, 2006, 127 (01) : 59 - 69
  • [7] DARVISHI K, 2007, CANC LETT
  • [8] Mutation analysis of peroxisome proliferator-activated receptor-γ coactivator-1 (PGC-1) and relationships of identified amino acid polymorphisms to Type II diabetes mellitus
    Ek, J
    Andersen, G
    Urhammer, SA
    Gæde, PH
    Drivsholm, T
    Borch-Johnsen, K
    Hansen, T
    Pedersen, O
    [J]. DIABETOLOGIA, 2001, 44 (12) : 2220 - 2226
  • [9] The Gly482Ser missense mutation of the Peroxisome Proliferator-activated receptor γ coactivator-1α (PGC-1α) gene associates with reduced insulin sensitivity in normal and glucose-intolerant obese subjects
    Fanelli, M
    Filippi, E
    Sentinelli, F
    Romeo, S
    Fallarino, M
    Buzzetti, R
    Leonetti, F
    Baroni, MG
    [J]. DISEASE MARKERS, 2005, 21 (04) : 175 - 180
  • [10] Splicing mosaic of the myophosphorylase gene due to a silent mutation in McArdle disease
    Fernandez-Cadenas, I
    Andreu, AL
    Gamez, J
    Gonzalo, R
    Martín, MA
    Rubio, JC
    Arenas, J
    [J]. NEUROLOGY, 2003, 61 (10) : 1432 - 1434